Trial to See if Topical Pennsaid for Knee Pain Affects Coagulation Values in Patients Who Are Also Taking Anticoagulants

PHASE3CompletedINTERVENTIONAL
Enrollment

22

Participants

Timeline

Start Date

February 29, 2012

Primary Completion Date

May 31, 2013

Study Completion Date

May 31, 2013

Conditions
Osteoarthritis of the KneeCoagulopathy
Interventions
DRUG

Pennsaid

Administered 10 drops x 4 until 40 drops applied topically to index knee (and also non-index knee if osteoarthritis pain is present bilaterally) 4 times a day for a 4 week active treatment period.

Trial Locations (1)

21702

Arthritis Treatment Center, Frederick

Sponsors

Collaborators (1)

All Listed Sponsors
collaborator

Medtronic - MITG

INDUSTRY

collaborator

Arthritis Treatment Center, Maryland

OTHER

lead

Nathan Wei, MD, FACP, FACR:

OTHER